| 引用本文： |
-
袁玲丹,宋利格.《原发性骨质疏松症诊疗指南（2022版）》解读[J].同济大学学报（医学版）,2023,44(6):777-784. [点击复制]
- YUAN Lingdan,SONG Lige.Interpretation of the Guidelines for the Diagnosis and Treatment of Primary Osteoporosis(2022)[J].Journal of Tongji University(Medical Science),2023,44(6):777-784. [点击复制]
|
|
| 摘要: |
| 由中华医学会骨质疏松和骨矿盐疾病分会制定的《原发性骨质疏松症诊疗指南（2022）》已于近期公布。该指南在2017版指南的基础上，整合了近5年来国内外关于原发性骨质疏松症的流行病学、发病机制、疾病诊断、治疗手段等方面的新进展，为原发性骨质疏松症的诊疗提供指导。本文就新指南的更新要点进行解读。 |
| 关键词: 骨质疏松 骨质疏松性骨折 诊疗指南 骨折风险 药物疗法 |
| DOI：10.12289/j.issn.1008-0392.23330 |
| 通信作者: |
| 投稿时间：2023-10-07 |
| 录用日期： |
| 基金项目: |
|
| Interpretation of the Guidelines for the Diagnosis and Treatment of Primary Osteoporosis(2022) |
| YUAN Lingdan,SONG Lige |
| (Department of Endocrinology, Tongji Hospital, School of Medicine, Tongji University, Shanghai 200065, China; Institute of Osteoporosis and Metabolic Bone Diseases, School of Medicine, Tongji University, Shanghai 200065, China; School of Medicine, Tongji University, Shanghai 200092, China) |
| Abstract: |
| Guidelines for the diagnosis and treatment of primary osteoporosis(2022) developed by the Chinese Society of Osteoporosis and Bone Mineral Research have been recently released. On the basis of the 2017 version, the current version of guidelines have incorporated the latest developments in the epidemiology, pathogenesis, disease diagnosis and treatment options for primary osteoporosis from both domestic and international sources over the past five years to provide guidance for clinical practice. This article interprets the main updates of the new guidelines. |
| Key words: osteoporosis osteoporotic fractures guidelines for diagnosis and treatment fracture risk drug therapy |
